ACCURATE Study for Subjects With Dry Eyes

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 16, 2019

Primary Completion Date

December 30, 2021

Study Completion Date

December 30, 2021

Conditions
Dry Eye Syndromes
Interventions
DRUG

Dextenza 0.4Mg Intracanalicular Insert

all patients will receive Intracanalicular dexamethasone, 0.4mg insert lower punctum and able to use over the counter artificial tears PRN at patient discretion

OTHER

Over the counter Artificial tears

over the counter artificial tears PRN at patient discretion

Trial Locations (1)

53405

The Eye Center of Racine, Racine

All Listed Sponsors
lead

The Eye Centers of Racine and Kenosha

OTHER

NCT04237012 - ACCURATE Study for Subjects With Dry Eyes | Biotech Hunter | Biotech Hunter